Paired related homeobox protein 2 (PRRX2)

Paired related homeobox protein 2 (PRRX2) is a DNA-binding transcription factor belonging to the paired family of homeobox proteins, expressed predominantly in proliferating fetal fibroblasts and during development of various mesenchymal tissues[1][5]. Its expression is associated with cellular proliferation, differentiation, and developmental processes, as well as with wound healing and scar prevention in fetal tissue[1][5]. PRRX2 plays a regulatory role in various pathological conditions, especially cancer, where its overexpression promotes tumor cell proliferation and impedes apoptosis—seen in lung adenocarcinoma and other malignancies[2]. Mechanistically, it exerts pro-proliferative and anti-apoptotic effects by transcriptionally activating genes such as PSMD1 and Wnt5a, contributing also to pathological processes like cardiac fibrosis following myocardial infarction via regulation of fibroblast differentiation and extracellular matrix production[2][3]. It is also implicated in several congenital disorders due to its developmental role. There are currently no drugs directly targeting PRRX2, and transcription factors remain difficult drug targets due to their intracellular location and DNA-binding nature[2].

Other names

Paired mesoderm homeobox protein 2PMX2PRX2PRX-2paired-like homeodomain protein PRX2testicular tissue protein Li 148testicular tissue protein Li 160paired-related homeobox protein 2

As a transcription factor, PRRX2 exerts its effects by binding to the promoter regions of target genes (such as Wnt5a, PSMD1, PLAT) and regulating their transcription, thereby influencing cell proliferation, apoptosis, and disease progression[2][3].